Kenya: East Africa's gateway.
An import-led market with one state buyer, a recognised regulator and a fast route for products already approved elsewhere.
52.2 million (2024 projection)
about 70%
about USD 705m (2024)
Pharmacy and Poisons Board
KEMSA
Large gaps in local supply.
Import-led
About 70% of medicines are imported.
Room on the list
Local makers produce 220 of the 1,096 formulations on the national essential medicines list.
One state buyer
KEMSA buys for the public sector.
Two routes, one regional format.
| Review target | When it applies | |
|---|---|---|
| Full review | 262 days | New products |
| Verification review | 90 days | Products already approved by reference authorities |
| Dossier format | CTD, mandatory | Across the East African Community |
Official targets. Real timelines add questions. Registrations are always held in your name.
One dossier, a whole region.
Products approved by reference authorities can qualify for the 90-day verification review.
Seven East African regulators share assessment work. A good Kenyan dossier travels.
Most essential formulations are not made locally. That is where demand waits.
Request a market read for Kenya.
Send us your portfolio. We reply within one working day.
- UK · WhatsApp
- +44 7466 253544
- Kazakhstan · WhatsApp
- +7 708 692 2409
- Pakistan
- +92 325 4307967
- [email protected]